1. Shaheen FA, Al-Khader AA. Epidemiology and causes of end-stage renal disease (ESRD). Saudi J Kidney Dis Transpl. 2005;16(3):277-281.

2. Bargman JM, Skorecki K. Chronic kidney disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine, 19th ed. New York: McGraw-Hill Education, 2015:1811-1821.

3. Liu KD, Chertow GM. Dialysis in the treatment of renal failure. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine, 19th ed. New York: McGraw-Hill Education, 2015:1822-1825.

4. Wasse H. Catheter-related mortality among ESRD patients. Semin Dial. 2008;21(6):547-549. 5- Naroienejad M, Saedi D, Rezvani A. Prevalence of central vein stenosis following catheterization in patients with end-stage renal disease. Saudi J Kidney Dis Transpl. 2010;21(5):975-978. 6- Jackson AJ, Coats P, Kingsmore DB. Pharmacotherapy to improve outcomes in vascular access surgery: a review of current treatment strategies. Nephrol Dial Transplant. 2012;27(5):2005-2016. 7- Ravari H, Banihashem A, Vejdani M, Kazemzadeh G. The efficacy of aspirin and dipyridamole on the patency of arteriovenous fistulae and grafts: review of the randomized control trials. Rev Clini Med. 2014;1(4):176-182.

5. Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, et al. Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol. 2011;22(4):773-781. [DOI:10.1681/ASN.2010060582] [PMID] []

6. Harrak H, Normand I, Grinker R, Elftouh N, Laurin L-P, Lafrance J-P. Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case-control study. BMC Nephrol [serial online]. 2015;16(1):50. Available from: [DOI:10.1186/s12882-015-0048-z.]

7. Shahmoradi MK, Khavaninzadeh M, Mousavi Kani K. Catheter-related complications and survival among Iranian ESRD patients treated in Hasheminejad hospital 2010-2011. Razi J Med Sci. 2013;19(105):21-27. [Full text in Persian]

8. Abdul-Rahman IS, Al-Howaish AK. Warfarin versus aspirin in preventing tunneled hemodialysis catheter thrombosis: a prospective randomized study. Hong Kong J Nephrol. 2007;9(1):23-30. [DOI:10.1016/S1561-5413(07)60005-2]

9. Tayebi P, Kazemzadeh G, Banihashem A, Ravari H. Effect of low-dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial. Electron Physician [serial online]. 2018;10(1):6135. Available from: https://doi.org/10.19082/6135 [DOI:10.19082/6135.] [PMID] []

10. Han L, Wang S-X, Wei W, Chen X, Shen S, Ling Y, et al. Thrombosis of the superior vena cava and auxiliary branches in patients with indwelling catheterization of the internal jugular vein. Chin Med J (Eng). 2009;122(6):692-696.

11. Napalkov P, Felici DM, Chu LK, Jacobs JR, Begelman SM. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord [serial online]. 2013;13(1):8. Available from: https://doi.org/10.1186/1471-2261-13-8 [DOI:10.1186/1471-2261-13-8.] [PMID] []

12. Chan MR. Hemodialysis central venous catheter dysfunction. Semin Dial. 2008;21(6):516-521. [DOI:10.1111/j.1525-139X.2008.00495.x] [PMID]